Research supported by Starr Cancer Consortium awards is reported in the following publications. The Starr Cancer Consortium is funded by the Starr Foundation.
MSMBuilder: Statistical Models for Biomolecular Dynamics.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer.
The aryl hydrocarbon receptor controls cell-fate decisions in B cells.